Hepatitis B immunisation programmes in European Union, Norway and Iceland: Where we were in 2009?

Vaccine

Volumn 28, Issue 28, 2010, Pages 4470-4477

  Mereckiene, Jolita ^a,b   Cotter, Suzanne ^a,b   Lopalco, Pierluigi ^c   D'Ancona, Fortunato ^b,e   Levy Bruhl, Daniel ^b,d   Giambi, Cristina ^b,e   Johansen, Kari ^c   Dematte, Luca ^b,g   Salmaso, Stefania ^b,e   Stefanoff, Pawel ^b,f   O'Flanagan, Darina ^a,b  

^a HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^b Vaccine European New Integrated Collaboration Effort (VENICE) Project   (Italy)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d Institut de Veille Sanitare   (France)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f NATIONAL INSTITUTE OF HYGIENE   (Poland)

^g CINECA   (Italy)

Author keywords

Hepatitis B; Immunisation; Selective vaccination; The VENICE project; Universal vaccination; Vaccine

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; ENDEMIC DISEASE; EUROPEAN UNION; FEMALE; FUNDING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEPATITIS B; HUMAN; ICELAND; IMMUNIZATION; INFANT; INTRAVENOUS DRUG ABUSE; LIFESTYLE; MALE; MASS SCREENING; NONHUMAN; NORWAY; OCCUPATIONAL HAZARD; PATIENT MONITORING; POPULATION RESEARCH; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; TREATMENT RESPONSE; CROSS-SECTIONAL STUDY; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA;

CROSS-SECTIONAL STUDIES; EUROPEAN UNION; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; ICELAND; IMMUNIZATION PROGRAMS; NATIONAL HEALTH PROGRAMS; NORWAY;

EID: 77953024658     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.037     Document Type: Article

References (25)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11 March (2) (2004) 97-107
2. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34 December (Suppl. 1) (2005) S1-S3
3. World Health Organization. Global situation (2008). http://www.who.int/nuvi/hepb/en/ Available online:
4. World Health Organization. Progress towards global immunisation goals - 2007. Summary presentation of key indicators (2008). http://www.who.int/immunization_monitoring/data/SlidesGlobalImmunization.pdf Available online:
5. World Health Organization. Hepatitis B fact sheet (2009). http://www.who.int/mediacentre/factsheets/fs204/en/index.html Available online:
6. Van Damme P., Van Herck K., Leuridan E., and Vorsters A. Introducing universal hepatitis B vaccination in Europe: differences still remain between countries. Euro Surveill 8 47 (2004)
7. Van Vliet J.A. Cost-effectiveness of national hepatitis B vaccination in the Netherlands. Euro Surveill 4 29 (2000)
8. Tilson L., Thornton L., O'Flanagan D., Johnson H., and Barry M. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation. Eur J Public Health 18 June (3) (2008) 275-282
9. Mereckiene J., Cotter S., Weber J.T., Nicoll A., Levy-Bruhl D., Ferro A., et al. Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill 13 October (41) (2008)
10. CINECA. 2009. Available online: http://www.cineca.it/en/index.htm.
11. StataCorp. STATA statistical software: release 10 (2007), College Station TSLP. Available online: http://www.stata.com
12. EUROHEP.NET. Data on surveillance and prevention of hepatitis A and B in 22 countries, 1991-2001 (2004). http://www.eurohep.net/ Available online:
13. Rantala M., and Van de Laar M.J. Surveillance and epidemiology of hepatitis B and C in Europe-a review. Euro Surveill 13 May (21) (2008)
14. World Health Organization. Introduction of hepatitis B vaccine into childhood immunisation services. Management guidelines, including information for health workers and parents (2001). http://www.who.int/vaccines-documents/DocsPDF01/www613.pdf Available online:
15. Gervais A., Longuet P., and Leport C. A success story: universal vaccination in Italy-what has to be done to eradicate residual acute hepatitis B?. Clin Infect Dis 46 March (6) (2008) 876-877
16. Mele A., Tosti M.E., Mariano A., Pizzuti R., Ferro A., Borrini B., et al. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 46 March (6) (2008) 868-875
17. Chen R.T., and Orenstein W.A. Epidemiologic methods in immunization programs. Epidemiol Rev 18 2 (1996) 99-117
18. Nardone A., Anastassopoulou C.G., Theeten H., Kriz B., Davidkin I., Thierfelder W., et al. A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect December (2008) 1-9
19. Gidding H.F., Warlow M., MacIntyre C.R., Backhouse J., Gilbert G.L., Quinn H.E., et al. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine 25 December (51) (2007) 8637-8641
20. François G., Hallauer J., and Van Damme P. Hepatitis B vaccination: how to reach risk groups. Vaccine 21 1-4 (2002)
21. Zuckerman J., Van Hattum J., Cafferkey M., Gjorup I., Hoel T., Rummukainen M.L., et al. Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?. Lancet Infect Dis 7 June (6) (2007) 410-419
22. Kroneman M., Paget W.J., and Van Essen G.A. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake. Euro Surveill 8 June (6) (2003) 130-138
23. Zanetti A.R., Van Damme P., and Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26 November (49) (2008) 6266-6273
24. Sonder G.J. Hepatitis B vaccination in travelers. Expert Rev Vaccines 7 July (5) (2008) 673-677
25. Zuckerman J.N., and Hoet B. Hepatitis B immunisation in travellers: poor risk perception and inadequate protection. Travel Med Infect Dis 6 September (5) (2008) 315-320